SLC1A2 and Parkinson disease: The abnormal expression of GLT‐1 is closely related to various neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), epilepsy, and autism.26